Ibandronate
Ibandronate is a pharmaceutical drug with 33 clinical trials. Historical success rate of 89.3%.
Success Metrics
Based on 25 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
5
Mid Stage
25
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
83.3%
25 of 30 finished
16.7%
5 ended early
0
trials recruiting
33
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Coral Calcium's Effect on Bone Density in Postmenopausal Women With and Without Ibandronate
Efficacy and Safety of Oral Ibandronate in Patients of Liver Cirrhosis With Hepatic Osteodystrophy.
Observational Study of Incidence Rates of Esophageal Cancer in Women Taking Medications for the Prevention or Treatment of Osteoporosis (MK-0217A-352)
Study of Investigational Drug in Osteoporosis (MK-0217-908)
Efficacy of Oral Ibandronate in Osteoporosis
Clinical Trials (33)
Coral Calcium's Effect on Bone Density in Postmenopausal Women With and Without Ibandronate
Efficacy and Safety of Oral Ibandronate in Patients of Liver Cirrhosis With Hepatic Osteodystrophy.
Observational Study of Incidence Rates of Esophageal Cancer in Women Taking Medications for the Prevention or Treatment of Osteoporosis (MK-0217A-352)
Study of Investigational Drug in Osteoporosis (MK-0217-908)
Efficacy of Oral Ibandronate in Osteoporosis
Study Of The Efficacy And Security Of Ibandronate For Osteoporosis Treatment In A HIV-Infected Patients Cohort
Prevention of Osteoporosis in Bone Marrow Transplantation (BMT) Patients
Bisphosphonate Action on the Appendicular Skeleton: Evidence for Differential Effects
Evaluation Of Missed Osteoporosis Diagnoses, And Preference Between Once Monthly Ibandronate And Once Weekly Alendronate
Study Comparing Ibandronate Versus Placebo in Hip Osteonecrosis
A Study To Assess the Quality and Strength of Bone in Women Participants With Osteoporosis Taking Oral Ibandronate Versus Placebo
A Study of Ibandronate (Bondronat) in Participants With Metastatic Bone Disease
A Study of Ibandronate (Bondronat) in Participants With Malignant Bone Disease
PRIOR Study - A Study of Ibandronate (Boniva) in Postmenopausal Women With Osteoporosis or Osteopenia
A Study of Ibandronate (Bonviva) in Patients With Post-Menopausal Osteoporosis
A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia
A Study To Assess The Quality Of Bone In Patients Taking Oral Ibandronate Versus Placebo
BONCURE Study: A Study of Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis on Bisphosphonate Therapy.
A Study of Adherence to Once Monthly Ibandronate (Bonviva) in Women With Post-Menopausal Osteoporosis, Supported by a Patient Relationship Program (PRP)
Comparison of Ibandronate - Zoledronate Regarding Nephrotoxicity in Multiple Myeloma
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 33